D Jäger Selected Research

D Jäger Research Topics

Disease

31	Neoplasms (Cancer) 12/2022 - 01/2000
6	Testicular Neoplasms (Testicular Cancer) 09/2001 - 01/2000
5	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 09/2007
4	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2001
4	Hypersensitivity (Allergy) 09/2001 - 01/2000
4	Melanoma (Melanoma, Malignant) 07/2000 - 02/2000
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2017 - 11/2007
3	Neoplasm Metastasis (Metastasis) 10/2015 - 05/2010
3	Hemorrhage 11/2013 - 09/2003
2	Carcinoma (Carcinomatosis) 01/2022 - 09/2007
2	Multiple Myeloma 11/2014 - 06/2006
2	Paraplegia (Spastic Paraplegia) 10/2006 - 09/2003
2	Colorectal Neoplasms (Colorectal Cancer) 06/2005 - 02/2003
2	Disease Progression 09/2001 - 01/2000
1	Residual Neoplasm 12/2022
1	Chordoma 01/2018
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 05/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2016
1	Esophageal Neoplasms (Esophageal Cancer) 10/2015
1	Hypertension (High Blood Pressure) 04/2015
1	Brain Neoplasms (Brain Tumor) 04/2015
1	Adenocarcinoma 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2014
1	Stomach Neoplasms (Stomach Cancer) 11/2013
1	Neoplasm Micrometastasis 05/2010
1	Rheumatoid Arthritis 01/2010
1	Ankylosing Spondylitis 01/2010
1	Osteoarthritis 01/2010
1	Psoriatic Arthritis 01/2010
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2008
1	Cardiomyopathies (Cardiomyopathy) 11/2007
1	Wounds and Injuries (Trauma) 09/2007
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2006

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 09/2004 - 01/2000
8	Neoplasm Antigens (Tumor Antigens)IBA 09/2004 - 01/2000
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2000
6	Peptides (Polypeptides)IBA 01/2001 - 01/2000
4	Gemcitabine FDA Link 08/2020 - 09/2007
4	EnzymesIBA 01/2010 - 02/2000
4	Differentiation AntigensIBA 09/2001 - 01/2000
3	Viral AntigensIBA 09/2001 - 01/2000
3	Complementary DNA (cDNA)IBA 03/2001 - 07/2000
3	Messenger RNA (mRNA)IBA 03/2001 - 07/2000
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2008
2	Fluorouracil (Carac)FDA LinkGeneric 08/2020 - 03/2015
2	Tyrosine Kinase InhibitorsIBA 12/2017 - 11/2007
2	AntibodiesIBA 05/2016 - 07/2000
2	PlatinumIBA 01/2016 - 06/2001
2	prothrombin complex concentrates (PPSB)IBA 10/2006 - 09/2003
2	prothrombin drug combination factor X factor VII factor IXIBA 10/2006 - 09/2003
2	plasma protein Z (protein Z)IBA 10/2006 - 09/2003
2	VaccinesIBA 01/2001 - 02/2000
1	B7-H1 AntigenIBA 12/2021
1	Capecitabine (Xeloda)FDA Link 08/2020
1	S100 Proteins (S 100 Protein)IBA 01/2018
1	VimentinIBA 01/2018
1	Brachyury protein (Brachyury)IBA 01/2018
1	pertuzumabIBA 05/2016
1	Cisplatin (Platino)FDA LinkGeneric 05/2016
1	Trastuzumab (Herceptin)FDA Link 05/2016
1	130-nm albumin-bound paclitaxelIBA 05/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 04/2015
1	InterferonsIBA 03/2015
1	Bortezomib (Velcade)FDA Link 11/2014
1	Bevacizumab (Avastin)FDA Link 11/2013
1	Liposomes (Liposome)IBA 05/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2012
1	ImmunosorbentsIBA 01/2010
1	AutoantibodiesIBA 01/2010
1	Serpin E2IBA 01/2010
1	Tumor Biomarkers (Tumor Markers)IBA 09/2008
1	Sunitinib (Sutent)FDA Link 11/2007
1	Toll-Like Receptor 2IBA 09/2007
1	macrophage stimulatory lipopeptide 2IBA 09/2007
1	CytokinesIBA 09/2007
1	ProstaglandinsIBA 06/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2006
1	Levofloxacin (Levaquin)FDA Link 06/2006

Therapy/Procedure

15	Therapeutics 12/2022 - 01/2000
6	Immunotherapy 10/2008 - 01/2000
4	Drug Therapy (Chemotherapy) 08/2020 - 09/2008
3	Neoadjuvant Therapy 12/2022 - 09/2013
3	Radiotherapy 11/2013 - 09/2008
1	Resistance Training 12/2017
1	Chemoradiotherapy 10/2015
1	Salvage Therapy 10/2015
1	Esophagectomy 10/2015
1	Duration of Therapy 04/2015
1	Nephrectomy 04/2015
1	Precision Medicine 03/2015
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2013
1	Adjuvant Chemotherapy 05/2010
1	Combination Drug Therapy (Combination Chemotherapy) 05/2010
1	Molecular Targeted Therapy 09/2008
1	Aftercare (After-Treatment) 11/2007
1	Anesthesia 12/2006